Podlesak Dennis's Form 4 filing
Syndax Pharmaceuticals IncSNDX · filed Sep 16, 2022
- Accession no.
- 0001562180-22-006705
- Filed
- Sep 16, 2022
- Trade date
- Sep 15-16, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.90M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Podlesak DennisCIK 0001314595 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 | Common Stock | MOption exerciseAcquired | +66,840 | $6.32 | +$422,428.8 | 142,603 | Direct | |
| Sep 15, 2022 | Common Stock | SSaleDisposed | −66,840 | $24.20F2 | −$1,617,528 | 75,763 | Direct | |
| Sep 16, 2022 | Common Stock | MOption exerciseAcquired | +5,419 | $6.32 | +$34,248.08 | 81,182 | Direct | |
| Sep 16, 2022 | Common Stock | SSaleDisposed | −5,419 | $23.43F3 | −$126,967.17 | 75,763 | Direct | |
| Sep 16, 2022 | Common Stock | MOption exerciseAcquired | +6,556 | $6.35 | +$41,630.6 | 82,319 | Direct | |
| Sep 16, 2022 | Common Stock | SSaleDisposed | −6,556 | $23.43F3 | −$153,607.08 | 75,763 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 | Common Stock | MOption exerciseDisposed | −66,840 | $0.00 | $0 | 0 | Direct | |
| Sep 16, 2022 | Common Stock | MOption exerciseDisposed | −6,556 | $0.00 | $0 | 0 | Direct | |
| Sep 16, 2022 | Common Stock | MOption exerciseDisposed | −5,419 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The sale prices ranged from $23.37 to $24.64
Referenced by the price of 1 transaction in Table I.
- F3
The sale prices ranged from $22.96 to $24.07
Referenced by the price of 2 transactions in Table I.